We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.08 | 0.07 | 0.09 | 0.08 | 0.08 | 0.08 | 0.00 | 07:30:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 1.78M | -1.28M | -0.0007 | -1.14 | 1.52M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/9/2022 06:44 | They desperately need the new box. They even more desperately need a new Chair and to start to level with usMain reason to hold is that losses are already huge and won't be much worse if it goes bustMrC | mrc2u | |
21/9/2022 06:40 | And they managed to get through £1m in cash in six months but this gets no mention and only have £0.6m left. Enough for another six or so weeks. Keen says they had been stocking up on old monitors and they still need to fund the years overdue new ones. Stock was £835,000 but cost of sales only £306,000 so more than a year of sales already in stockSome honesty would help MrC | mrc2u | |
21/9/2022 06:29 | The interim statement had some positive vibes, as ever, from Mr Keen, who has been Chair for half the late Queen's reign. As ever also, it was a load of hot air!He made much of the growth in the international division where sales were up by £156,000 but fails to mention that without a single order back in January for $200,000, this business would have gone backwards MrC | mrc2u | |
20/9/2022 14:29 | Will the last one out please turn off the lights | trentendboy | |
20/9/2022 12:31 | I'm still here | bigt20 | |
20/9/2022 12:25 | Not been in this for some years. Reminds me of Sphere. Similar traction issues, mainly due to inherent conservatism of approach by users and payers. One issue they had was when they updated their monitor, it led to the inevitable sales shortfall as any new orders await the new version. They never made the numbers and ended up gong bust (one of the Woodford stable). | waterloo01 | |
20/9/2022 12:18 | Level 2 improving as the buys trickle in. It’s not going to take much for the price to move back up | nobbygnome | |
20/9/2022 11:16 | Yes for me this update was relatively good. A couple of new US accounts and the real key the new monitor coming shortly. That will drive turnover in the short term and greatly improve cash flow | nobbygnome | |
20/9/2022 11:13 | I'm still here. | gnnmartin | |
20/9/2022 07:26 | Allenby initiating in the coming weeks but they believe the stage is set for growth to accelerate and deliver on the clear potential........ | chrisdgb | |
20/9/2022 07:04 | Yes, some optimism I would say, I have spoken to people in the healthcare sector in recent months and procedures are definitely coming through now..... | chrisdgb | |
20/9/2022 07:00 | Anybody still here? | maxk | |
30/8/2022 09:29 | Have Allenby ever done any company research.....??? | chrisdgb | |
31/7/2022 09:21 | Is the share price ever going to get moving upwards again? BoD have been very slow. | bugsbunny10 | |
21/7/2022 14:52 | Nice to see some bottom feeder buying, and the 500k person still loading up!! | gbenson1 | |
19/7/2022 21:47 | www.finsmes.com/2022 Here is Retia, another PPWA player. Been around for a few years. Not very good: PPWA never is but people buy it because its easy and this one claims to be easy to set up, although reliant on an invasive line. Now got stacks of cash, $15m, to spend on marketing. That's about 300 years' worth of DEMG's marketing budget and likely to be effective However, DEMG have a lot of clinician followers and a big installed base so ought to be able to put their foot on the gas as soon as they get the new monitor launched. Lets hope for definitive news on regulatory approvals and launch dates with the interims | schloo | |
19/7/2022 20:34 | >>DJAnd Natalie Wettler, the newish CFO, first joined in 2011BTW where is that new monitor??MrC | mrc2u | |
19/7/2022 18:50 | mrC2u and..... Mr. Mears, aged 49, started at Deltex as an engineer in 1989 | dj trading | |
19/7/2022 11:53 | >>>BugsKeen has been a director since the 1980sCazalet since 2008Jones since 2015Wippell since 2014Irish since 2021 (well 2014 first time round)Any correlation with the stagnation?MrC | mrc2u | |
19/7/2022 10:54 | We needed a new lease of life. Still a lot of work to do behind the scenes to get this share price moving. Nearly 10 years stagnation. | bugsbunny10 | |
15/7/2022 12:28 | Agreed. Good to see that they are down to one broker. They needed to change advisers and have now done so, even though it was forced upon them. Just shows how much they need a new board and new chair to at least try to take control of events.They need a new monitor. It is close, but where is it?And a new marketing story.MrC | mrc2u | |
14/7/2022 06:38 | It would be nice if Allenby did a decent note on the company......... | chrisdgb | |
12/7/2022 08:35 | Let us hope you are right. But, if they have spent a good part of £1 million building inventory, why not say so?Furthermore, why spend all that money yet and give only a vague indication of when they might actually launch the new monitor?Smells a bit off to meMrC | mrc2u | |
11/7/2022 22:30 | The cash may have been spent on building up finished goods inventory (monitors, probes) to be sold in the second half of the year and paying payables. While we have receivables to collect. I look forward to seeing the Interims in order to get some clarity. | bigt20 | |
11/7/2022 08:40 | Serious point about the wishy-washy waffle of the latest trading updateCash of £0.6m. But they raised £1.4m in February. As they had £0.4m at December 2021, that makes £1.2m burnt since. That's £200,000 a month. What on earth is going on???And where is the new monitor???MrC | mrc2u |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions